These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17721300)

  • 1. Safety profile of bevacizumab on cultured human corneal cells.
    Yoeruek E; Spitzer MS; Tatar O; Aisenbrey S; Bartz-Schmidt KU; Szurman P
    Cornea; 2007 Sep; 26(8):977-82. PubMed ID: 17721300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells.
    Spitzer MS; Yoeruek E; Sierra A; Wallenfels-Thilo B; Schraermeyer U; Spitzer B; Bartz-Schmidt KU; Szurman P
    Graefes Arch Clin Exp Ophthalmol; 2007 Dec; 245(12):1837-42. PubMed ID: 17347807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cytotoxic effects of bevacizumab on human corneal cells.
    Chalam KV; Agarwal S; Brar VS; Murthy RK; Sharma RK
    Cornea; 2009 Apr; 28(3):328-33. PubMed ID: 19387236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells.
    Spitzer MS; Wallenfels-Thilo B; Sierra A; Yoeruek E; Peters S; Henke-Fahle S; Bartz-Schmidt KU; Szurman P;
    Br J Ophthalmol; 2006 Oct; 90(10):1316-21. PubMed ID: 16723358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of bevacizumab-induced toxicity for cultured human corneal fibroblasts.
    Kim EK; Kang SW; Kim JY; Min K; Kim TI
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3922-31. PubMed ID: 23640039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic properties of sunitinib and sorafenib on human corneal epithelial cells.
    Bayyoud T; Hofmann J; Spitzer M; Bartz-Schmidt KU; Yoeruek E
    Curr Eye Res; 2014 Feb; 39(2):149-54. PubMed ID: 24073630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic effects of recombinant tissue plasminogen activator on cultured human corneal endothelial cells.
    Yoeruek E; Spitzer MS; Tatar O; Biedermann T; Grisanti S; Lüke M; Bartz-Schmidt KU; Szurman P
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1392-7. PubMed ID: 18385055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab application delays epithelial healing in rabbit cornea.
    Kim TI; Chung JL; Hong JP; Min K; Seo KY; Kim EK
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4653-9. PubMed ID: 19458331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human anterior lens capsule as carrier matrix for cultivated human corneal endothelial cells.
    Yoeruek E; Saygili O; Spitzer MS; Tatar O; Bartz-Schmidt KU; Szurman P
    Cornea; 2009 May; 28(4):416-20. PubMed ID: 19411960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the transport of and cytotoxic effects for nalbuphine solution in corneal cells.
    Spatola RA; Thangavelu M; Upadhyayula V; Lee S; Phelps MA; Chandler HL
    Am J Vet Res; 2012 Dec; 73(12):1987-95. PubMed ID: 23176428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety profile of topical VEGF neutralization at the cornea.
    Bock F; Onderka J; Rummelt C; Dietrich T; Bachmann B; Kruse FE; Schlötzer-Schrehardt U; Cursiefen C
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2095-102. PubMed ID: 19151400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization.
    Chen WL; Chen YM; Chu HS; Lin CT; Chow LP; Chen CT; Hu FR
    PLoS One; 2014; 9(4):e94205. PubMed ID: 24714670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decellularization of porcine corneas and repopulation with human corneal cells for tissue-engineered xenografts.
    Yoeruek E; Bayyoud T; Maurus C; Hofmann J; Spitzer MS; Bartz-Schmidt KU; Szurman P
    Acta Ophthalmol; 2012 Mar; 90(2):e125-31. PubMed ID: 22136333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bevacizumab on apoptosis, Na+ -K+ -adenosine triphosphatase and zonula occludens 1 expression on cultured corneal endothelial cells.
    Yoeruek E; Tatar O; Spitzer MS; Saygili O; Biedermann T; Bartz-Schmidt KU; Thaler S; Szurman P
    Ophthalmic Res; 2010; 44(1):43-9. PubMed ID: 20173357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of differential toxicity of varying doses of bevacizumab on retinal ganglion cells, retinal pigment epithelial cells, and vascular endothelial growth factor-enriched choroidal endothelial cells.
    Brar VS; Sharma RK; Murthy RK; Chalam KV
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):507-11. PubMed ID: 20028259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery.
    Li Z; Van Bergen T; Van de Veire S; Van de Vel I; Moreau H; Dewerchin M; Maudgal PC; Zeyen T; Spileers W; Moons L; Stalmans I
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5217-25. PubMed ID: 19474408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ranibizumab (Lucentis®) and bevacizumab (Avastin®) on human corneal endothelial cells.
    Merz PR; Röckel N; Ballikaya S; Auffarth GU; Schmack I
    BMC Ophthalmol; 2018 Dec; 18(1):316. PubMed ID: 30537942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrotic activity of bevacizumab on human Tenon's fibroblasts in vitro.
    O'Neill EC; Qin Q; Van Bergen NJ; Connell PP; Vasudevan S; Coote MA; Trounce IA; Wong TT; Crowston JG
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6524-32. PubMed ID: 20574016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of trypan blue with human corneal cells.
    van Dooren BT; Beekhuis WH; Pels E
    Arch Ophthalmol; 2004 May; 122(5):736-42. PubMed ID: 15136322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of in vitro effects of bevacizumab (Avastin) on retinal pigment epithelial, neurosensory retinal, and microvascular endothelial cells.
    Luthra S; Narayanan R; Marques LE; Chwa M; Kim DW; Dong J; Seigel GM; Neekhra A; Gramajo AL; Brown DJ; Kenney MC; Kuppermann BD
    Retina; 2006; 26(5):512-8. PubMed ID: 16770256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.